Clinical Trial Update: Fluoxetine in Pulmonary Arterial Hypertension (PAH) Trial [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating fluoxetine for pulmonary arterial hypertension has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Fluoxetine (Fluoxetine)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Pulmonary Arterial Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2019-10-07